Chronic atrophic gastritis
Conditions
Interventions
Weifuchun group:In addition to conventional treatment, Weifuchun is also used. Weifuchun is administered orally, 4 pills/time, 3 times/day. (Specification: 0.35g/pill, Hangzhou Huqing Yutang Pharmac
Non Weifuchun group:According to clinical diagnosis and treatment guidelines, corresponding western medicine treatment is used, including acid suppressants, gastric mucosal protectants, folic acid, et
Sponsors
The First Affiliated Hospital of Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Gastroscopy and histopathological examination meet the diagnostic criteria for CAG; 2) The TCM syndrome differentiation is spleen and stomach weakness type; 3) Age range from 18 to 85 years old, gender not limited; 4) The patient has good compliance, voluntarily participates in this trial, and signs an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Accompanied by mental illness; 2) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological grading of gastric mucosa;Traditional Chinese Medicine Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| OLGA/OLGIM;Endoscopic classification of gastritis;adverse event;Blood routine, urine routine, stool routine, fecal occult blood, liver function, kidney function, electrocardiogram; | — |
Countries
China
Contacts
Public ContactHuang Xuan
The First Affiliated Hospital of Zhejiang Chinese Medical University
Outcome results
None listed